These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8101772)

  • 1. Effects of long-term enalapril therapy on left ventricular diastolic properties in patients with depressed ejection fraction. SOLVD Investigators.
    Pouleur H; Rousseau MF; van Eyll C; Stoleru L; Hayashida W; Udelson JA; Dolan N; Kinan D; Gallagher P; Ahn S
    Circulation; 1993 Aug; 88(2):481-91. PubMed ID: 8101772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
    Konstam MA; Kronenberg MW; Rousseau MF; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
    Circulation; 1993 Nov; 88(5 Pt 1):2277-83. PubMed ID: 8222122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional remodeling and nonuniform changes in diastolic function in patients with left ventricular dysfunction: modification by long-term enalapril treatment. The SOLVD Investigators.
    Hayashida W; Van Eyll C; Rousseau MF; Pouleur H
    J Am Coll Cardiol; 1993 Nov; 22(5):1403-10. PubMed ID: 8227798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in ventricular volume, wall thickness and wall stress during progression of left ventricular dysfunction. The SOLVD Investigators.
    Pouleur HG; Konstam MA; Udelson JE; Rousseau MF
    J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):43A-48A. PubMed ID: 8376696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
    Konstam MA; Rousseau MF; Kronenberg MW; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
    Circulation; 1992 Aug; 86(2):431-8. PubMed ID: 1638712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy.
    Greenberg B; Quinones MA; Koilpillai C; Limacher M; Shindler D; Benedict C; Shelton B
    Circulation; 1995 May; 91(10):2573-81. PubMed ID: 7743619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early treatment with low-dose enalapril after acute myocardial infarction: an equilibrium radionuclide angiographic study. Enalapril despues del Infarto (EDI) Trial Investigators.
    Bazzino O; Navarro Estrada JL; Sosa Liprandi A; Presti C; Masoli O; Santopinto J; Ahuad A; Amuchástegui M; Méndez R
    J Nucl Cardiol; 1997; 4(2 Pt 1):133-9. PubMed ID: 9115065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit of converting enzyme inhibition on left ventricular volumes and ejection fraction in patients receiving beta-blockade after myocardial infarction. CONSENSUS II multiecho study group.
    Bonarjee VV; Carstensen S; Caidahl K; Nilsen DW; Edner M; Lindvall K; Snapinn SM; Berning J
    Am Heart J; 1996 Jul; 132(1 Pt 1):71-7. PubMed ID: 8701878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.
    Colucci WS; Kolias TJ; Adams KF; Armstrong WF; Ghali JK; Gottlieb SS; Greenberg B; Klibaner MI; Kukin ML; Sugg JE;
    Circulation; 2007 Jul; 116(1):49-56. PubMed ID: 17576868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contractile state is the major determinant of functional outcome in patients with left ventricular dysfunction treated with enalapril.
    Mirsky I; Aoyagi T; Ihara T; van Eyll C; Rousseau MF; Pouleur H
    Eur Heart J; 1995 Jun; 16(6):808-17. PubMed ID: 7588925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular filling after long-term angiotensin converting enzyme inhibition in congestive heart failure.
    Baur LH; Schipperheyn JJ; Cats VM; van der Wall EE; Baan J; van Dijk AD; Bruschke AV
    Eur Heart J; 1992 Nov; 13 Suppl E():52-6. PubMed ID: 1478210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular unloading and improvement in left ventricular function after angiotensin converting enzyme inhibition with enalapril in patients with chronic congestive heart failure.
    Naganuma F; Kubota S; Hirahara N; Imai K; Kamiyama H; Iizuka T; Imai S; Murata K; Suzuki T
    Jpn Circ J; 1994 Jan; 58(1):34-42. PubMed ID: 8139090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of preload reserve as a determinant of clinical status in patients with left ventricular systolic dysfunction. The SOLVD Investigators.
    Konstam MA; Kronenberg MW; Udelson JE; Kinan D; Metherall J; Dolan N; Edens T; Howe D; Kilcoyne L; Benedict C
    Am J Cardiol; 1992 Jun; 69(19):1591-5. PubMed ID: 1598875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
    Knight EL; Glynn RJ; McIntyre KM; Mogun H; Avorn J
    Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
    Yan RT; White M; Yan AT; Yusuf S; Rouleau JL; Maggioni AP; Hall C; Latini R; Afzal R; Floras J; Masson S; McKelvie RS;
    Am J Cardiol; 2005 Sep; 96(5):698-704. PubMed ID: 16125499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of early enalapril therapy on left ventricular function and structure in acute myocardial infarction.
    Schulman SP; Weiss JL; Becker LC; Guerci AD; Shapiro EP; Chandra NC; Siu C; Flaherty JT; Coombs V; Taube JC
    Am J Cardiol; 1995 Oct; 76(11):764-70. PubMed ID: 7572651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy.
    Lin M; Chiang HT; Lin SL; Chang MS; Chiang BN; Kuo HW; Cheitlin MD
    J Am Coll Cardiol; 1994 Oct; 24(4):1046-53. PubMed ID: 7930196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurohormonal effects of early treatment with enalapril after acute myocardial infarction and the impact on left ventricular remodelling.
    Sigurdsson A; Held P; Swedberg K; Wall B
    Eur Heart J; 1993 Aug; 14(8):1110-7. PubMed ID: 8404942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study).
    Foy SG; Crozier IG; Turner JG; Richards AM; Frampton CM; Nicholls MG; Ikram H
    Am J Cardiol; 1994 Jun; 73(16):1180-6. PubMed ID: 8203335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker.
    White M; Rouleau JL; Afzal R; Floras J; Yusuf S; McKelvie RS
    Ther Adv Cardiovasc Dis; 2009 Apr; 3(2):113-21. PubMed ID: 19299427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.